z-logo
open-access-imgOpen Access
ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome
Author(s) -
Donna F. Vine,
Lawrence J. Beilin,
Sally Burrows,
RaeChi Huang,
Martha Hickey,
Roger Hart,
Spencer D. Proctor,
Trevor A. Mori
Publication year - 2020
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvaa061
Subject(s) - polycystic ovary , medicine , dyslipidemia , lipoprotein(a) , endocrinology , apolipoprotein b , context (archaeology) , lipoprotein , cholesterol , obesity , insulin resistance , biology , paleontology
Fasting plasma apoB48-lipoprotein remnants but not apoB100-lipoprotein remnants were elevated in adolescent girls with increased cardiometabolic risk compared with those with lower cardiometabolic risk (13.91 ± 5.06 vs 12.09 ± 4.47 µg/mL, < .01). ApoB48-lipoprotein remnants were positively correlated with fasting plasma triglycerides (b = .43, < .0001). The prevalence of increased cardiometabolic risk factors was 2-fold higher in those diagnosed with PCOS (35.3%) than in those without PCOS (16.3%). Adolescents with PCOS have a 2-fold higher incidence of cardiometabolic risk factors than those without PCOS. Fasting apoB48-lipoprotein remnants are elevated in adolescent girls with a high prevalence of cardiometabolic risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom